For local information please click here
|
Lundbeck focuses on providing severely ill patient populations with innovative and effective therapies that satisfy unmet medical needs.  Our three core areas of focus are:
Lundbeck has a portfolio of 19 products in the U.S. for conditions such as Acute Intermittent Porphyria, chorea associated with Huntington’s disease, hereditary antithrombin deficiency and Wilm’s Tumor.  |
Please visit Customer Support for important contact information relating to our products, including:
*Â Dial 911 if you are experiencing a medical emergency. * |